Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1999 Nov;67(5):607–612. doi: 10.1136/jnnp.67.5.607

Progressive polyradiculoneuropathy in diabetes: correlation of variables and clinical outcome after immunotherapy

S Jaradeh 1, T Prieto 1, L Lobeck 1
PMCID: PMC1736606  PMID: 10519866

Abstract

OBJECTIVE—To quantify the progression of diabetic polyradiculoneuropathy—a condition in which immune factors have been implicated—after immunotherapy.
METHODS—The study evaluated 15 consecutive patients with this condition. All patients were older than 40. Four had type I diabetes and six were women. The duration of pre-existing diabetes varied from 2 to 20 years. The clinical presentation was dominated by painful progressive motor weakness, with or without exacerbation of sensory symptoms. The weakness involved all limbs, but was often asymmetric.
RESULTS—Electrophysiological testing showed a predominantly axonal polyneuropathy, with more recent denervating polyradiculopathy. Analysis of CSF showed increased protein in 14 and oligoclonal bands in five. Quantitative autonomic tests showed abnormalities in all patients. Sural nerve biopsy was performed in 14 patients; all showed fibre loss and segmental demyelination, four had occasional onion bulbs, and 10 showed various inflammatory infiltrates. After immunomodulating therapy, there was no further deterioration and clinical improvement occurred in all patients. Sweat responses, cardiovascular reflexes, and sural nerve fibre density correlated best with functional outcome. There was no significant difference between plasmapheresis and intravenous gammaglobulin.
CONCLUSION—Immunotherapy may improve this condition, but only certain variables correlate with rapid therapeutic response.



Full Text

The Full Text of this article is available as a PDF (97.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abu-Shakra S. R., Cornblath D. R., Avila O. L., Chaudhry V., Freimer M., Glass J. D., Reim J. W., Ronnett G. V. Conduction block in diabetic neuropathy. Muscle Nerve. 1991 Sep;14(9):858–862. doi: 10.1002/mus.880140910. [DOI] [PubMed] [Google Scholar]
  2. Albers J. W., Kelly J. J., Jr Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve. 1989 Jun;12(6):435–451. doi: 10.1002/mus.880120602. [DOI] [PubMed] [Google Scholar]
  3. Barohn R. J., Kissel J. T., Warmolts J. R., Mendell J. R. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol. 1989 Aug;46(8):878–884. doi: 10.1001/archneur.1989.00520440064022. [DOI] [PubMed] [Google Scholar]
  4. Barohn R. J., Sahenk Z., Warmolts J. R., Mendell J. R. The Bruns-Garland syndrome (diabetic amyotrophy). Revisited 100 years later. Arch Neurol. 1991 Nov;48(11):1130–1135. doi: 10.1001/archneur.1991.00530230038018. [DOI] [PubMed] [Google Scholar]
  5. Brown F. M., Brink S. J., Freeman R., Rabinowe S. L. Anti-sympathetic nervous system autoantibodies. Diminished catecholamines with orthostasis. Diabetes. 1989 Jul;38(7):938–941. doi: 10.2337/diab.38.7.938. [DOI] [PubMed] [Google Scholar]
  6. Cornblath D. R., Griffin D. E., Welch D., Griffin J. W., McArthur J. C. Quantitative analysis of endoneurial T-cells in human sural nerve biopsies. J Neuroimmunol. 1990 Feb;26(2):113–118. doi: 10.1016/0165-5728(90)90082-x. [DOI] [PubMed] [Google Scholar]
  7. Dyck P. J., Kratz K. M., Karnes J. L., Litchy W. J., Klein R., Pach J. M., Wilson D. M., O'Brien P. C., Melton L. J., 3rd, Service F. J. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993 Apr;43(4):817–824. doi: 10.1212/wnl.43.4.817. [DOI] [PubMed] [Google Scholar]
  8. Dyck P. J., Litchy W. J., Kratz K. M., Suarez G. A., Low P. A., Pineda A. A., Windebank A. J., Karnes J. L., O'Brien P. C. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol. 1994 Dec;36(6):838–845. doi: 10.1002/ana.410360607. [DOI] [PubMed] [Google Scholar]
  9. Dyck P. J., Sherman W. R., Hallcher L. M., Service F. J., O'Brien P. C., Grina L. A., Palumbo P. J., Swanson C. J. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol. 1980 Dec;8(6):590–596. doi: 10.1002/ana.410080608. [DOI] [PubMed] [Google Scholar]
  10. Guy R. J., Richards F., Edmonds M. E., Watkins P. J. Diabetic autonomic neuropathy and iritis: an association suggesting an immunological cause. Br Med J (Clin Res Ed) 1984 Aug 11;289(6441):343–345. doi: 10.1136/bmj.289.6441.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ingall T. J., McLeod J. G., Tamura N. Autonomic function and unmyelinated fibers in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 1990 Jan;13(1):70–76. doi: 10.1002/mus.880130113. [DOI] [PubMed] [Google Scholar]
  12. Kennedy W. R., Navarro X., Goetz F. C., Sutherland D. E., Najarian J. S. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med. 1990 Apr 12;322(15):1031–1037. doi: 10.1056/NEJM199004123221503. [DOI] [PubMed] [Google Scholar]
  13. Kornberg A. J., Pestronk A. The clinical and diagnostic role of anti-GM1 antibody testing. Muscle Nerve. 1994 Jan;17(1):100–104. doi: 10.1002/mus.880170115. [DOI] [PubMed] [Google Scholar]
  14. Krendel D. A., Costigan D. A., Hopkins L. C. Successful treatment of neuropathies in patients with diabetes mellitus. Arch Neurol. 1995 Nov;52(11):1053–1061. doi: 10.1001/archneur.1995.00540350039015. [DOI] [PubMed] [Google Scholar]
  15. Mancardi G. L., Cadoni A., Zicca A., Schenone A., Tabaton M., De Martini I., Zaccheo D. HLA-DR Schwann cell reactivity in peripheral neuropathies of different origins. Neurology. 1988 Jun;38(6):848–851. doi: 10.1212/wnl.38.6.848. [DOI] [PubMed] [Google Scholar]
  16. Pollard J. D., McCombe P. A., Baverstock J., Gatenby P. A., McLeod J. G. Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol. 1986 Dec;13(2):123–134. doi: 10.1016/0165-5728(86)90059-7. [DOI] [PubMed] [Google Scholar]
  17. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology. 1991 May;41(5):617–618. [PubMed] [Google Scholar]
  18. Said G., Elgrably F., Lacroix C., Planté V., Talamon C., Adams D., Tager M., Slama G. Painful proximal diabetic neuropathy: inflammatory nerve lesions and spontaneous favorable outcome. Ann Neurol. 1997 Jun;41(6):762–770. doi: 10.1002/ana.410410612. [DOI] [PubMed] [Google Scholar]
  19. Said G., Goulon-Goeau C., Lacroix C., Moulonguet A. Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol. 1994 May;35(5):559–569. doi: 10.1002/ana.410350509. [DOI] [PubMed] [Google Scholar]
  20. Said G., Goulon-Goeau C., Slama G., Tchobroutsky G. Severe early-onset polyneuropathy in insulin-dependent diabetes mellitus. A clinical and pathological study. N Engl J Med. 1992 May 7;326(19):1257–1263. doi: 10.1056/NEJM199205073261905. [DOI] [PubMed] [Google Scholar]
  21. Said G., Slama G., Selva J. Progressive centripetal degeneration of axons in small fibre diabetic polyneuropathy. Brain. 1983 Dec;106(Pt 4):791–807. doi: 10.1093/brain/106.4.791. [DOI] [PubMed] [Google Scholar]
  22. Schrøder H. D., Olsson T., Solders G., Kristensson K., Link H. HLA-DR-expressing cells and T-lymphocytes in sural nerve biopsies. Muscle Nerve. 1988 Aug;11(8):864–870. doi: 10.1002/mus.880110811. [DOI] [PubMed] [Google Scholar]
  23. Simmons Z., Albers J. W., Bromberg M. B., Feldman E. L. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy. Neurology. 1993 Nov;43(11):2202–2209. doi: 10.1212/wnl.43.11.2202. [DOI] [PubMed] [Google Scholar]
  24. Stewart J. D., McKelvey R., Durcan L., Carpenter S., Karpati G. Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics. J Neurol Sci. 1996 Oct;142(1-2):59–64. doi: 10.1016/0022-510x(96)00126-8. [DOI] [PubMed] [Google Scholar]
  25. Van Lis J. M., Jennekens F. G., Veldman H. Calcium deposits in the perineurium and their relation to lipid accumulation. J Neurol Sci. 1979 Nov;43(3):367–375. doi: 10.1016/0022-510x(79)90016-9. [DOI] [PubMed] [Google Scholar]
  26. Vital C., Dumas P., Latinville D., Dib M., Vital A., Brechenmacher C. Relapsing inflammatory demyelinating polyneuropathy in a diabetic patient. Acta Neuropathol. 1986;71(1-2):94–99. doi: 10.1007/BF00687968. [DOI] [PubMed] [Google Scholar]
  27. Walk D. Immunotherapy of neuropathies in patients with diabetes mellitus requires closer scrutiny. Arch Neurol. 1996 Jul;53(7):590–592. doi: 10.1001/archneur.1996.00550070020006. [DOI] [PubMed] [Google Scholar]
  28. Younger D. S., Rosoklija G., Hays A. P., Trojaborg W., Latov N. Diabetic peripheral neuropathy: a clinicopathologic and immunohistochemical analysis of sural nerve biopsies. Muscle Nerve. 1996 Jun;19(6):722–727. doi: 10.1002/(SICI)1097-4598(199606)19:6<722::AID-MUS6>3.0.CO;2-C. [DOI] [PubMed] [Google Scholar]
  29. Zanone M. M., Peakman M., Purewal T., Watkins P. J., Vergani D. Autoantibodies to nervous tissue structures are associated with autonomic neuropathy in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1993 Jun;36(6):564–569. doi: 10.1007/BF02743275. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES